Shiku, Hiroshi
Mie University Graduate School of Medicine,
Japan
2025 Rank: 95965
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 2588 out of 166615 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 95965 | 97474 |
| Total Cites | 14621 | 17331 |
| H-index | 61 | 67 |
| Hm-index | 23 | 24 |
| Number of Single Authored Papers | 10 | 10 |
| Total Cites to Single Authored Papers | 47 | 47 |
| Number of Single+First Authored Papers | 23 | 23 |
| Total Cites to Single+First Authored Papers | 175 | 190 |
| Number of Single+First+Last Authored Papers | 290 | 290 |
| Total Cites to Single+First+Last Authored Papers | 6350 | 7409 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 12524 | 13815 |
| Ratio of Total Citations to Distinct Citing Papers | 1.17 | 1.25 |
| Self-Citation Percentage |
15.64%
|
|
Shiku, Hiroshi
Mie University,
Japan
2024 Rank: 91567
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 2520 out of 157372 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 91567 | 91242 |
| Total Cites | 13960 | 16676 |
| H-index | 60 | 67 |
| Hm-index | 22 | 24 |
| Number of Single Authored Papers | 10 | 10 |
| Total Cites to Single Authored Papers | 47 | 47 |
| Number of Single+First Authored Papers | 23 | 23 |
| Total Cites to Single+First Authored Papers | 169 | 184 |
| Number of Single+First+Last Authored Papers | 290 | 290 |
| Total Cites to Single+First+Last Authored Papers | 6103 | 7151 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 11924 | 13220 |
| Ratio of Total Citations to Distinct Citing Papers | 1.17 | 1.26 |
| Self-Citation Percentage |
16.29%
|
|
Shiku, Hiroshi
Mie University Graduate School of Medicine,
Japan
2023 Rank: 89366
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 2500 out of 147556 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 89366 | 90628 |
| Total Cites | 13262 | 15933 |
| H-index | 59 | 64 |
| Hm-index | 22 | 24 |
| Number of Single Authored Papers | 10 | 10 |
| Total Cites to Single Authored Papers | 44 | 44 |
| Number of Single+First Authored Papers | 23 | 23 |
| Total Cites to Single+First Authored Papers | 157 | 172 |
| Number of Single+First+Last Authored Papers | 296 | 296 |
| Total Cites to Single+First+Last Authored Papers | 5833 | 6864 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 11320 | 12596 |
| Ratio of Total Citations to Distinct Citing Papers | 1.17 | 1.26 |
| Self-Citation Percentage |
16.76%
|
|
Shiku, Hiroshi
Mie University Graduate School of Medicine,
Japan
2022 Rank: 84562
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 2426 out of 138599 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 84562 | 85240 |
| Total Cites | 12436 | 15046 |
| H-index | 57 | 63 |
| Hm-index | 21 | 23 |
| Number of Single Authored Papers | 10 | 10 |
| Total Cites to Single Authored Papers | 43 | 43 |
| Number of Single+First Authored Papers | 23 | 23 |
| Total Cites to Single+First Authored Papers | 151 | 166 |
| Number of Single+First+Last Authored Papers | 291 | 291 |
| Total Cites to Single+First+Last Authored Papers | 5487 | 6490 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 10612 | 11860 |
| Ratio of Total Citations to Distinct Citing Papers | 1.17 | 1.27 |
| Self-Citation Percentage |
17.35%
|
|
Shiku, Hiroshi
Mie University,
Japan
2021 Rank: 81710
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 2367 out of 127911 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 81710 | 81640 |
| Total Cites | 12000 | 14587 |
| H-index | 57 | 63 |
| Hm-index | 21 | 23 |
| Number of Single Authored Papers | 10 | 10 |
| Total Cites to Single Authored Papers | 43 | 43 |
| Number of Single+First Authored Papers | 23 | 23 |
| Total Cites to Single+First Authored Papers | 140 | 155 |
| Number of Single+First+Last Authored Papers | 290 | 290 |
| Total Cites to Single+First+Last Authored Papers | 5288 | 6280 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 10242 | 11473 |
| Ratio of Total Citations to Distinct Citing Papers | 1.17 | 1.27 |
| Self-Citation Percentage |
17.73%
|
|
Shiku, Hiroshi
Mie University School of Medicine,
Japan
2020 Rank: 77985
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 2224 out of 108509 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 77985 | 76559 |
| Total Cites | 11262 | 13785 |
| H-index | 55 | 61 |
| Hm-index | 21 | 23 |
| Number of Single Authored Papers | 10 | 10 |
| Total Cites to Single Authored Papers | 41 | 41 |
| Number of Single+First Authored Papers | 23 | 23 |
| Total Cites to Single+First Authored Papers | 135 | 150 |
| Number of Single+First+Last Authored Papers | 289 | 289 |
| Total Cites to Single+First+Last Authored Papers | 4950 | 5916 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 9580 | 10773 |
| Ratio of Total Citations to Distinct Citing Papers | 1.18 | 1.28 |
| Self-Citation Percentage |
18.30%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.